Inhibition of ANXA5 by Gemcitabine (score:98.78) and Vinorebine (score:94.29) and inhibition of PCGF6 by Paclitaxel (score:98.70) reduced the risk of AF. This evidence concerns the gene ANXA5 and atrial fibrillation.